| Etude | Sponsor / Promoteur | Titre du projet |
| ADAPT | CHU Limoges | Adjunctive DobutAmine in sePtic cardiomyopathy with Tissue hypoperfusion: a randomized controlled multi-center trial |
| ADRESS PILOT | CHU Dijon Bourgogne | Alpha 2 agonist dexmedetomidine for sympathetic Deactivation in REfractory Septic Shock |
| AFTER ROSC | CHU Nantes | Comparison of Scores for Early Brain Damage Assessment at Intensive Care Unit Admission After Out of Hospital Cardiac Arrest (AfterROSC1) |
| AMIDIAL ICU | CHU Reims | Prescription Strategies of Amikacin in Intensive Care Patients on Renal Replacement Therapy: an Observational Prospective Multicenter Study |
| AR-301-002 | ARIDIS Pharmaceuticals | Placebo-controlled, double-blind, randomized study of Salvecin as adjunct therapy to antibiotics in the treatment of S.aureus pneumonia |
| ARBs CORONA II | University of British Columbia | Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan on Outcomes of Coronavirus Infection? |
| ASTONISH MOT-C-203 | INOTREM | Efficacy, safety and tolerability of Nangibotide in Patients with Septic Shock |
| BICARICU-2 | CHU Montpellier | Traitement adjuvant des acidoses métaboliques et ou mixtes sévères avec insuffisance rénale aigüe modérée à sévère par bicarbonate de sodium : étude prospective multicentrique randomisée et contrôlée |
| CF301 | ContraFect Corporation | A Multicenter, Multinational, Double-Blind, Randomized, Placebo-Controlled Comparative Study of the Safety, Tolerability, Efficacy, and Pharmacokinetics of CF-301 vs. Placebo on a Background of Standard-of-Care Antibacterial Therapy for the Treatment of Adult Patients with Staphylococcus Aureus Bloodstream Infections Including Right-Sided Endocarditis |
| COVID-ICU | Centre hospitalier la Pitié Salpêtrière | Infection à Covid-19 en réanimation Etude de cohorte multicentrique |
| DISCOVERY | Inserm | Multicenter, adaptative, randomized trial of safety and efficacy on treatments of Covid-19 in hospitalized adults |
| EARLY MOB | ||
| ESSENTIAL MOT-C204 | INOTREM | Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support and Features of Systemic Inflammation. |
| EVERDAC | CHR Orléans et CHU Tours | Insertion systématique précoce d’un cathéter artériel versus insertion différée au cours de l’insuffisance circulatoire aiguë (PHRC National 2017) |
| FIXATUB | Vendée CHD | Comparison of Two Methods of Securing Endotracheal Tubes in Intensive Care : Elastic Adhesive Strips vs Lace In A Protective Sheath |
| FLUNEXT | CHRU Lille | Validation de l'efficacité anti-grippale de molécules repositionnées sur la base de leur signature cellulaire transcriptomique antagoniste de celles liées à l'infection par le virus Influenza A |
| FRENCH COVID-19 | Inserm | Protocole de caractérisation clinique des infections émergentes sévères |
| HIGH FLOW ACRF | Assistance Publique - Hôpitaux de Paris | Use of Nasal High Flow Oxygen During Breaks of Non-invasive Ventilation for Patients With Hypercapnic Respiratory Failure |
| IDAST | Assistance Public - Hopitaux de Paris | Optimisation personnalisée du traitement antibiotique des patients présentant un sepsis pulmonaire par l'utilisation combinée de test rapide d'identification bactérienne et de son antibiogramme, et de modélisation pharmacokinétique/pharmacodynamique |
| ILIAD-7 | REVIMMUNE | Etude multi cohorte multicentrique randomisée en double aveugle contrôlée versus placebo évaluant le traitement de l'interleukine-7 humaine recombinante (CYT107) pour améliorer les résultats cliniques chez les patients lymphopéniques infectés par le coronavirus |
| IOXSOR | CHU Angers | Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure (IOXSOR) |
| PREDIGAZ | CHR Orléans | Prediction of Arterial Lactate and Blood Gas Values Through the Analysis of Central Venous Blood (PREDIGAZ) |
| PROCOCO | Assistance Public - Hopitaux de Paris | Corticothérapie guidée par le dosage du procollagène 3 au cours des syndromes de détresse respiratoire aiguë persistants |
| PTSD Réa | CH Chartres | Reducing Post-traumatic Stress Disorder After ICU Discharge With the IPREA3 Program (PTSD-REA) |
| RECORDS | AP-HP Hopital Raymond Poincaré, CIC 1429 Centre d'Investigation Clinique | Rapid rEcognition of Corticosteroid Resistant or sentive in Sepsis |
| RECOVIDS | CHU Dijon Bourgogne | Functional Recovery From Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19: Influence of Socio-Economic Status (RECOVIDS) |
| REMAP-CAP | MJM Bonten, UMC Utrecht | Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia (REMAP-CAP) |
| REVIVAL | AM Pharma | Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI |
| SEPSIR | CHU Angers | Relation Between Mean Arterial Pressure and Renal Resistive Index in the Early Phase of Septic Shock (SEPSIR) |
| SESAR | CHRU Clermont Ferrand | SEvoflurane for Sedation in ARds (SESAR) |
| SOHO | CHU Poitiers | Impact on mortality of a strategy including Standard Oxygen versus High flow nasal cannula Oxygen therapy in patients with acute respiratory failure: a Prospective, Randomized Controlled Trial. |
| TAVEM 2 | CHRU Lille | Antimicrbiol Treatment in Patients with Ventilator Associated Tracheotomitis (TAVeM2) |
| TRACH WEAN | Prise en charge des patients trachéotomisés pour un sevrage ventilatoire en réanimation, de la mise en place de la trachéotomie à la décanulation : étude prospective observationnelle de cohorte multicentrique |